About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

The Chicago Board Options Exchange Volatility Index (VIX) is near a one-week high, having risen 2.48 points to 20.05.

2026-02-13

The Chicago Board Options Exchange Volatility Index (VIX) is near a one-week high, having risen 2.48 points to 20.05.

Other News
2026-02-12

U.S. EIA natural gas inventories for the week ending February 6 were -249 billion cubic feet, compared to an expected -257 billion cubic feet and a previous -360 billion cubic feet.

U.S. EIA natural gas inventories for the week ending February 6 were -249 billion cubic feet, compared to an expected -257 billion cubic feet and a previous -360 billion cubic feet.
2026-02-12

Individual Stock News: 1. NetEase (09999.HK) announced its 2025 results: net profit attributable to shareholders of approximately RMB 33.76 billion, a year-on-year increase of 13.68%. 2. NetEase Cloud Music (09899.HK) announced its 2025 results: ad

Individual Stock News: 1. NetEase (09999.HK) announced its 2025 results: net profit attributable to shareholders of approximately RMB 33.76 billion, a year-on-year increase of 13.68%. 2. NetEase Cloud Music (09899.HK) announced its 2025 results: adjusted net profit of approximately RMB 2.86 billion, a year-on-year increase of 68.2%. 3. Q Technology (01478.HK): January sales of mobile phone camera modules reached 41.482 million units, a decrease of 3.7% month-on-month and an increase of 19.5% year-on-year. 4. Value Partners Group (00806.HK) issued a profit warning: expecting a significant increase in consolidated profit attributable to owners of the company to approximately HKD 660 million in 2025. 5. China Resources Power (00836.HK): January electricity sales from its subsidiary power plants reached 23,788,790 MWh, an increase of 28.4% year-on-year. 6. Ribobio (06938.HK) entered into an exclusive global licensing agreement with Madrigal for certain siRNA assets. The Group will receive an initial payment of US$60 million, with a cumulative payment of US$4.4 billion, plus potential royalties from net sales, if certain development, regulatory, and commercialization milestones are achieved. 7. Seazen Holdings (01030.HK) completed a placement of 198 million shares, raising net proceeds of approximately HK$469 million. 8. GigaDevice (03986.HK) issued 4.3373 million shares due to the full exercise of its over-allotment option. 9. Road King (01098.HK): Total property sales in 2025 are projected to be RMB 7.39 billion, a decrease of 40.7% year-on-year. 10. Hengrui Medicine (01276.HK): Trastuzumab for injection was included in the Breakthrough Therapy List.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.